Original article. Inmunoprotector potential of cellular vaccine formulations developed from Leptospira interrogans Ballum using Mesocricetus auratus as biomodel

1. Panamerican Health Organization. Poors desease [Internet]. 2009 [cited 2009 Mar 4]. Available from: http://www.paho.org/Spanish/AD/DPC/CD/psit-ndposter.htmSearch in Google Scholar

2. Brenner D, Kaufmann A, Sulzer K, Steigerwalt A, Rogers F, Weyant R. Further determination of DNA relatedness between serogroups and serovars in the family Leptospiraceae with a proposal for Leptospira alexanderi sp. and four new Leptospira genomospecies. Int J Syst Bacteriol. 1999; 49:839-58.10.1099/00207713-49-2-839Open DOISearch in Google Scholar

3. Adler B, de la Peña M. Leptospira and Leptospirosis. Vet Microbiol. 2009; 2:4382-92.Search in Google Scholar

4. Levett P. Leptospirosis. Clin Microbiol Rev. 2001; 14: 296-326.10.1128/CMR.14.2.296-326.2001Open DOISearch in Google Scholar

5. Cinco M, Domenis R, Perticarari S, Presani G, Marangoni A, Blasi E. Interaction of leptospires with murine microglial cells. New Microbiol. 2006; 29:193-9.Search in Google Scholar

6. McBride A, Athanazio D, Reis M, Ko A. Leptospirosis. Curr Opin Infect Dis. 2005; 18:376-86.10.1097/01.qco.0000178824.05715.2cOpen DOISearch in Google Scholar

7. WHO/FAO/OIE Collaborating Centre for Reference and Research on Leptospirosis. National Leptospirosis Surveillance Report number 17 [Internet]. 2009 [cited 2009 Mar 4]. Available from: http://www.health.qld.gov.au/qhcss/documents/lepto/08_annual.pdf;2009Search in Google Scholar

8. World Health Organization. WHO Guidelines on Non-clinical Evaluation of Vaccines. 2003.Search in Google Scholar

9. Faine S. Leptospira and Leptospirosis. Clayton, Victoria, Australia: CRC Press. 1994.Search in Google Scholar

10. Haake D, Chao G, Zuerner R, Barnett J, Barnett D, Mazel M. The leptospiral major outer membrane protein LipL32 is a lipoprotein expressed during mammalian infection. Infect Immun. 2000; 68:2276-85.10.1128/IAI.68.4.2276-2285.2000Open DOISearch in Google Scholar

11. Andre-Fontaine G, Branger C, Gray A, Klaasen H. Comparison of the efûcacy of three commercial bacterins in preventing canine leptospirosis. Vet Rec. 2003; 153:165-9.10.1136/vr.153.6.165Open DOISearch in Google Scholar

12. Wan Z, Jin L, Wegrzyn A. Leptospirosis vaccines. Microb Cell Fac. 2007; 6:1-10.10.1186/1475-2859-6-1Open DOISearch in Google Scholar

13. Martínez R, Pérez A, Baró M, Alvarez M, Menéndez J, Díaz M. Evaluation of the effectiveness of a new vaccine against human leptospirosis in groups at risk. Rev Panam Sal Pub. 2000; 8:385-92.Search in Google Scholar

14. Rodríguez I, Fernández C, Obregon A, Zamora Y, Rodríguez J, Rodríguez N. Epidemological behavior of the leptospirosis in Cuba 2006-2008, Leptospirosis Havana 2009. Proceedings of I SAW Scientific Meeting, 2009 Jun 8-12; Havana, Cuba.Search in Google Scholar

15. Haake D. Hamster model of leptospirosis. Curr Protoc Microb. 2006 Sep;Chapter 12:Unit 12E.2.10.1002/9780471729259.mc12e02s02Open DOISearch in Google Scholar

16. Silva E, Santos S, Athanazio D, Seyffert N, Seixas F, Cerqueira G. Characterization of virulence of Leptospira isolates in a hamster model. Vaccine. 2008; 26:3892-6.10.1016/j.vaccine.2008.04.085Open DOISearch in Google Scholar

17. González M, Martínez R, Cruz R, Infante J, González I. vax-SPIRALR. Trivalent antileptospirosic vaccine for human use, investigation, development and impact on the illness in Cuba. Biotec. Aplic. 2004; 2:107-11.Search in Google Scholar

18. American Veterinary Medical Association. Guidelines on Euthanasia. Fromerly report of the AVMA panel on Euthanasia; 2007.Search in Google Scholar

19. Silva E, Medieros M, Mc Bride A, Matasunga J, Esteves G, Ramos J. The terminal portion of leptospiral immunoglobulin-like protein Lig A confers protective immunity against lethal infection in the hamster model of leptospirosis. Vaccine. 2007; 25:6277-86.10.1016/j.vaccine.2007.05.053Open DOISearch in Google Scholar

20. Reed J, Muench H. simple method of estimation ûfty percent end-points. American Journal of Hygiene. 1938; 27:493-7.Search in Google Scholar

21. Finlay Institute. Sanitary Registration of vax- SPIRAL (trivalent antileptospirosic vaccine); 1998. p.23-25.Search in Google Scholar

22. Freudenstein H, Hein B. Potency of Leptospiral vaccines and protection against chronic infection in golden hamsters. Comp Immunol Microb Infect Dis. 1991; 14:229-34.10.1016/0147-9571(91)90003-VOpen DOISearch in Google Scholar

23. Tepstra W, Hartskeerl R, Smits H, Korver H. International Course in Laboratory Techniques for the Diagnosis of Leptospirosis. KIT Biomedical Research. International. Royal Tropical Institute, Amsterdam, 2006, 1-124.Search in Google Scholar

24. Hem A, Smith A, Solberg P. Saphenous vein puncture for blood sampling of the mouse, rat, hamster, gerbil, guinea pig, ferret, and mink. Lab Anim. 1998; 32:364-8.10.1258/002367798780599866Open DOISearch in Google Scholar

25. Silva M, Camargo E, Batista L, Vaz A, Brandao A, Nakamura P. Behaviour of specific IgM, IgG and IgA class antibodies in human leptospirosis during the acute phase of the disease and during convalescence. J Trop Med Hyg. 1995; 98:268-72.Search in Google Scholar

26. Nu ez J, Fajardo E, Perez E, Ontivero I, Silva D, Munoz P. Evaluation of two different potency tests for leptospirosis vaccine vax-spiral. Rev Cub Med Tropic. 2005; 57:67-8.Search in Google Scholar

27. Falkow S. Molecular Koch’s postulates applied to microbial pathogenicity. Rev Infect Dis. 1988; 10: 274-6.10.1093/cid/10.Supplement_2.S274Open DOISearch in Google Scholar

28. Shenberg E, Torten M. A new leptospiral vaccine for use in man. I. Development of a vaccine from Leptospira grown in a chemicacally defined medium. J Inf Dis.1973; 128:642-6.10.1093/infdis/128.5.642Open DOISearch in Google Scholar

29. Levett P, Morey R, Gallowway R, Turner D, Steigerwalt A, Mayer L. Detection of pathogenic leptospires by real-time quantitative real-time PCR. J Med Microbiol. 2005; 54:45-9.10.1099/jmm.0.45860-0Open DOISearch in Google Scholar

30. Matsunaga J, Barocchi M, Croda J, Young T, Sanchez Y, Siqueira I. Pathogenic Leptospira species express surface-exposed proteins belonging to the bacterial immunoglobulin superfamily. Molecul Microbiol. 2003; 49:929-46.10.1046/j.1365-2958.2003.03619.xOpen DOISearch in Google Scholar

31. Choy H, Kelley M, Chen T, Moller A, Matsunaga J, Haake D. Physiological osmotic induction of Leptospira interrogans adhesion: LigA and LigB bind extracellular matrix proteins and fibrinogen. Infect Immun. 2007; 75:2441-50.10.1128/IAI.01635-06Open DOISearch in Google Scholar

32. Gonzalez A, Rodriguez Y, Batista N, Valdes Y, Nu ez J, Gonzalez M. Booster effect of an active immunization with Leptospira interrogans serogroup Ballum in hamsters vaccinated with vax-SPIRAL. Vacci Monitor. 2003; 12:1-6.Search in Google Scholar

33. Faine S, Adler B, Bolin C, Perolat P: Leptospira and Leptospirosis. 2nd edition. Melbourne, Australia: MediSci; 1999.Search in Google Scholar

34. Sonrier C, Branger C, Michel V, Ruvoen N, Ganiere J, Andre G. Evidence of cross-protection within Leptospira interrogans in an experimental model. Vaccine. 2000; 19:86-94.10.1016/S0264-410X(00)00129-8Open DOISearch in Google Scholar

35. Coutinho ML, Choy HA, Kelley MM, Matsunaga J, Babbitt JT, Lewis M, Aleixo JA, Haake D. A LigA Three- Domain Region Protects Hamsters from Lethal Infection by Leptospira interrogans. PLoS Negl Trop Dis. 2011; 5:e1422. 10.1371/journal.pntd.0001422323672122180800Open DOISearch in Google Scholar